A randomised trial of vindesine plus interferon-α2b compared with interferon-α2b or vindesine alone in the treatment of advanced malignant melanoma
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (6) , 797-800
- https://doi.org/10.1016/0959-8049(94)90295-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Etiology and epidemiology of melanoma and skin neoplasmsCurrent Opinion in Oncology, 1991
- Phase II Study of Interferon α-2a and Dacarbazine in Advanced MelanomaAmerican Journal of Clinical Oncology, 1990
- Interferon α-2a and Dacarbazine in MelanomaJNCI Journal of the National Cancer Institute, 1990
- Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II studyCancer, 1989
- Regression analyses of prognostic factors in metastatic malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Intralesional interferon-alpha therapy in advanced malignant melanomaCancer, 1988
- Regulation of cell growth by interferonCancer and Metastasis Reviews, 1987